Manufacturer of traditional medicinal products. The company has two plasma collection stations and markets its immunoglobulin products in more than 20 provinces and autonomous regions in China.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Zhengzhou RAAS Blood Products Company‘s full profile, request access.
Request a free trial